Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes

Dec 17, 2025The New England journal of medicine

Heart health outcomes with Tirzepatide compared to Dulaglutide in Type 2 diabetes

AI simplified

GLP-1 TherapiesGLP-1 Therapies on OpenScience ↗PubMed ↗DOI ↗

Full Text

Full text is available at the source.
View full text ↗

Related papers

Apr '25
Comparing Increasing Dulaglutide Dose to Switching to Tirzepatide in People with Type 2 Diabetes Not Controlled by Low Dulaglutide
top 2% journal
cited by 3 papers
randomized controlled trial
Oct '18
Safety and effectiveness of LY3298176, a new drug targeting two hormone receptors, in people with type 2 diabetes: a controlled phase 2 trial
top 1% journal
cited by 699 papers
randomized controlled trial
Aug '22
Effectiveness and safety of tirzepatide alone versus dulaglutide in Japanese adults with type 2 diabetes
top 1% journal
cited by 183 papers
randomized controlled trial
Jul '14
Comparing once-weekly dulaglutide and once-daily liraglutide in type 2 diabetes patients taking metformin
top 1% journal
cited by 409 papers
randomized controlled trial

Featured in

GLP-1 TherapiesGLP-1 TherapiesIssue #16
Not a panacea: weight regain after stopping GLP-1s varies by medication, while 25-40% of loss is lean mass
↗

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #28
Semaglutide linked to 74-fold higher risk of vision-threatening eye condition
6 days ago3 studies
issue #27
GLP-1 drugs linked to 18% lower risk of substance use disorders in 524,817 veterans
1 week ago7 studies
issue #26
86.5% of patients on semaglutide or tirzepatide lost at least 5% of body weight at 6 months in Medicaid study
2 weeks ago7 studies
issue #25
GLP-1 drugs linked to 20% lower dementia risk in diabetic kidney patients
3 weeks ago7 studies
issue #24
Tirzepatide beats semaglutide for weight loss by 6.1% in head-to-head comparison
4 weeks ago7 studies
issue #23
Bariatric Surgery vs. GLP-1s for cardiovascular risk
5 weeks ago7 studies
issue #22
GLP-1 drugs linked to better pregnancy rates in PCOS women and reduced cancer risk in diabetes patients
6 weeks ago7 studies
issue #21
GLP-1 drugs may fight addiction, and reduce alcohol consumption
7 weeks ago7 studies
issue #20
GLP-1 drugs show promise for kidney transplant patients and Alzheimer's, but may increase eye problems
8 weeks ago7 studies
issue #19
GLP-1 drugs cut heart attack risk by 22% vs competitors, but may increase vision loss risk
9 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief